Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Busiest Dealmakers Of 2022

2022 Deal-Making Led By Sanofi, J&J And Roche

Dec 01 2022

• By Joseph Haas

Busy — • Source: Shutterstock

Related Content

After Cutting Back And Clinging On, Will Biotech Bounce Back In 2023?

Nov 16 2022

Seagen Taps Epstein As New CEO After A Tumultuous Year

Nov 10 2022

Pfizer's Dolsten On Finding Ways To “Accelerate External Science”

Nov 04 2022

BMS Is Latest To Join Synthetic Lethality Bandwagon With Volastra Deal

Mar 21 2022

Sanofi Dives Back Into ADCs With Seagen Pact

Mar 17 2022

Sanofi Will Employ Adagene’s Technology For Precision Targeting In Cancer

Mar 02 2022

2021 Deal Snapshot: Continued Emphasis On Bolt-Ons, Alliances Up

Apr 01 2022

Sanofi Bets Big On IgM ‘Super Antibodies’ In Potential $6bn Cancer and Immunology Deal

Mar 29 2022

Deal Watch: AbbVie Adds Neuroscience Heft With Syndesi Acquisition

Mar 01 2022

Roche Goes Big On KRAS-Mutated Cancers In Hookipa Pact

Oct 20 2022

Lilly Builds On Gene Therapy Focus With Akouos Takeout

Oct 18 2022

Deal Watch: Aging-Focused Calico Taps Start-Up Terray For Discovery

Oct 13 2022

Ex-Sanofi Partnering Chief Wants AI Start-Up Owkin To Be Industry Leader

Oct 04 2022

Sanofi ThiNKs Scribe’s CRISPR Approach Can Advance Its NK Cell Therapy Goals

Sep 27 2022

Roche Buys IL-2 Technology From Good, Which Forms New Firm Bonum

Sep 07 2022

Deal Watch: Novo Nordisk Links With Flagship To Create Cardiometabolic, Rare Disease Portfolio

May 12 2022

China Deal Watch: Four Biotechs Kick Off May With Multiple In/Out Deals

May 10 2022

Pfizer To Put Big Marketing Muscle Behind Migraine With Biohaven Purchase

May 10 2022

Ups And Downs In Protein Degraders: Big Deals For BMS, Merck KGaA, Safety Worries For Kymera

May 05 2022

Merck & Co Closing In On Seagen Acquisition

Jul 08 2022

Deal Watch: Ovid Teams With Gensaic On Phage-Derived, Gene-Delivered Therapies

Aug 25 2022

Sanofi Looks To Atomwise For More AI Help

Aug 17 2022

Deal Watch: Gemini Goes Through Second Re-Invention Via Reverse Merger With Disc Medicine

Aug 10 2022

Pfizer’s Buying Spree Continues With GBT, Gaining A Sickle Cell Disease Franchise

Aug 08 2022

Deal Watch: Organon Obtains Rights To Perjeta, Prolia/Xgeva Biosimilars From Shanghai Henlius

Jun 15 2022

BMS Hopes Turning Point Buyout Will Fare Better Than Roche’s Ignyta Acquisition

Jun 03 2022

The Next Big Patent Cliff Is Coming, And Time Is Running Out To Pad The Fall

Apr 04 2022

Asia Deal Watch: Taiho Brings Cullinan Pearl Back In House

May 17 2022

Deal Watch: BMS Licenses Bispecific TCR Candidate From Immatics

Dec 17 2021

Evotec Adds To Spate Of Metabolic Deals With Lilly Collaboration

Jan 18 2022

Beam Anticipates Pfizer Deal Will Lead To Additional Partnerships

Jan 12 2022

ABL’s Bispecific Antibody For Parkinson's Lands In Sanofi’s Hands

Jan 13 2022

Deal Watch: Bristol, Pfizer Lead Off J.P. Morgan Week With Two Deals Apiece

Jan 11 2022

Deal Watch: J&J Begins 2022 With Trio Of Technology Alliances

Jan 07 2022

Exscientia And Sanofi Will Search For 15 Novel Oncology, Immunology Drugs Under New Pact

Jan 07 2022

Pfizer Shopping For Deals That Will Add $25bn To 2030 Revenues

Feb 09 2022

Deal Watch: Amgen Taps Plexium's Expertise In Targeted Protein Degradation

Feb 09 2022

A Biopharma M&A Bonanza In 2022? Analysts Pick Top Targets And Likely Buyers

Feb 02 2022

J&J Jumps On RNA-Based Small Molecules Train In Pact With Remix

Feb 17 2022

Related Companies

Pfizer Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Merck & Co., Inc.

Acceleron Pharma, Inc.

NexImmune, Inc.

Twist Bioscience Corporation

Eli Lilly and Company

Roche Holding AG

Genentech, Inc.

Johnson & Johnson

Sanofi

Additional Topics

M & A Deals Companies Commercial Business Strategies Growth Market Intelligence Strategy Outlook 2023 BioPharmaceutical

More from Outlook Archive

More from Outlook

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window